Ident. | Authors (with country if any) | Title |
---|
003518 (2002) |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
003526 (2002) |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; HONG YI [Japon] | Dopamine-derived endogenous N-methyl-(R)-salsolinol its role in Parkinson's disease |
003546 (2002) |
Toshiharu Nagatsu [Japon] | Amine-related neurotoxins in Parkinson's disease: Past, present, and future |
003680 (2001) |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
003827 (2001) |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Alain Piriou [France] ; Bernard Fauconneau [France] | Impairment of the neuronal dopamine transporter activity in MPP+-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors |
003832 (2001) |
W. Maruyama [Japon] ; A. A. Boulton [Canada] ; B. A. Davis [Canada] ; P. Dostert [France] ; M. Naoi [Japon] | Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells : Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine |
003849 (2001) |
Stéphanie Barc [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Laurence Barrier [France] ; Francois Huguet [France] | A new in vitro approach for investigating the MPTP effect on DA uptake |
003850 (2001) |
David Blum [Belgique, France] ; Sakina Torch [France] ; Marie-France Nissou [France] ; Jean-Marc Verna [France] | 6-hydroxydopamine-induced nuclear factor-kappab activation in PC12 cells |
003B57 (2000) |
A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France] | The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation |
003B70 (2000) |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
003B75 (2000) |
N. W. Kowall [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] ; A. C. Mckee [États-Unis] ; R. J. Ferrante [États-Unis] | MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons |
003B98 (2000) |
Wakako Maruyama [Japon] ; Kumiko Sango [Japon] ; Kinuko Iwasa [Japon] ; Chiyoko Minami [Japon] ; Philippe Dostert [France] ; Masao Kawai [Japon] ; Masataka Moriyasu [Japon] ; Makoto Naoi [Japon] | Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4')-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells : apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines |
003C10 (2000) |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihito Akao [Japon] ; JIN ZHANG [Japon] ; Hasan Parvez [France] | Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons |
003C12 (2000) |
P. Jenner [Royaume-Uni] ; B.-Y. Zeng [Royaume-Uni] ; L. A. Smith [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] ; B. Tel [Royaume-Uni] ; L. Chancharme [France] ; G. Moachon [France] | Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset |
003C82 (1999) |
Carine Fillebeen [France] ; Valérie Mitchell [France] ; David Dexter [Royaume-Uni] ; Monique Benaissa [France] ; Jean-Claude Beauvillain [France] ; Geneviève Spik [France] ; Annick Pierce [France] | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment |
003D61 (1999) |
Valérie Ben [France] ; Olivier Blin [France] ; Bernard Bruguerolle [France] | Time‐dependent Striatal Dopamine Depletion after Injection of 6‐Hydroxydopamine in the Rat. Comparison of Single Bilateral and Double Bilateral Lesions |
003E47 (1999) |
Erwan Bezard [France] ; Christian E. Gross [France] ; Marie-Christine Fournier [France] ; Sandra Dovero [France] ; Bertrand Bloch [France] ; Mohamed Jaber [France] | Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter |
003F06 (1999) |
R. J. Ferrante [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] | Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase |
004081 (1998) |
Th Boraud [France] ; E. Bezard [France] ; D. Guehl [France] ; B. Bioulac [France] ; Ch Gross [France] | Effects of l-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey |
004111 (1998) |
J. Hugon [France] | Neurologie tropicale et facteurs toxiques |
004140 (1998) |
H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël] | Physiology of MPTP tremor |